Preparing stock dashboard...

PRF Technologies Ltd.

PRFX - NasdaqCM - Healthcare - Drug Manufacturers - Specialty & Generic

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

PRF Technologies Ltd. trades as PRFX on NasdaqCM in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. Its latest stored price is $1.86 as of June 3, 2026.

Data updated June 3, 2026

Price
$1.86

Financial Snapshot

Metric Value ('000,000)

Stock Analysis

Scores this stock using the same metrics model as the compare page.

Metric Value Score

Price Chart

Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.

Drag window to pan. Drag edges to resize visible range.